It is possible that inhibiting ovulation can reduce the risk of ovarian cancer among women who ovulate more frequently throughout the course of their lifetimes.
Obese women who take oestrogen and progestin-containing oral contraceptives have a 24-fold greater risk of venous thromboembolism (VTE) compared to non-obese women who do not use the medicines.
